People with obesity perhaps familiar with this drug as administered agent, Sibutramine, due to treats their diabetes.
Recently some country had observed about safety of this drug.
In the UK, this drug suspended related the safety concern.

In the US market, this drug branded as Meridia, Reductil and Sibutex. Manufactured by Abbott Laboratories.

Recently FDA warned the manufacture that should be labeled for ‘not to use’ with patient that have cardiovascular history including with the patients that have history of;

- coronary artery disease
- stroke or transient iscemic attack
- heart atthythmias
- congestive heart failure
- peripheral arterial disease
- uncontrolled high blood pressure (more than 145/90 mm Hg)

This warning based on data of 10,000 obese patients with have vary of above precaution disease history from the data at the Sibutramine Cardiovascular Outcomes Trial (SCOUT).

FDA noted to healthcare professional to monitor patients blood pressure due taking sibutramine.

EMEA, the Europe Medicines Agency issued press released related to the result data that “the risk of these medicines are greater than their benefits.”

Now in the UK and Europe country suspend the marketing authorization for these medicines.
Brand marketing of Sibutramine in UK and Europe are Reduxade, Reductil, and Zelium.

Moreover EMEA stated to the physicians should no longer prescribe Sibutramine administered agent, pharmaceutical should no longer dispense them, and the patients who had consume this medicine should seeing their physicians again.

Related posts:

1. Complications for the patient with Ankylosing Spondylitis, increasing risk of MI, including (when already had history of MI) hypertension, dylipidemia, diabetes, and raise of BMI A form of spongdyloarthritis, Ankylosing Spondylitis is chronic disease of...
2. espite adverse effect to cardiovascular risks, researcher believed the new combo drug for weight loss is safe and meaningful to loss the weight Recently, researchers said that a new obesity drug with over...
3. Fake counterfeit Alli weight loss drug sold in the net, the maker complaint! Fake weight loss drug from counterfeit Alli announced by FDA...
4. Alert: FDA recommend to withdrawn the Midodrine drug due to insuffiecient benefits data Due to insufficient data for its benefit from Midodrine hydrochloride...
5. Alert, avoid uses combination of HIV drug therapy with Saquinavir and Ritonavir including drug classes IA and III, Arrythmia! Latest alert from FDA to all physician and patients when...

Visitor Guidance :::MOUSE OVER YOUR POINTER TO THE HOMEOPATHIC AND NATURAL IMAGE PRODUCTS FOR SHORT PRODUCTS DESCRIPTION (YOUR JAVASCRIPT BROWSER MUST BE ENABLE) OR SEE IN ABOVE SUB-CATEGORIES::: Return to HOMEPAGE.